Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
mechanisms understanding and optimize treatment for mental health using computational tools, with a particular focus on developing ecologically valid computational frameworks and models. Our research uses both
-
, and functions as Yale Health’s flagship Epic Physician Builder. The role provides physician-level informatics leadership for Epic optimization, clinical decision support, workflow improvement, AI
-
. Develop and optimize genome and epigenome editing workflows in neuronal or neural progenitor systems. Generate, analyze, and interpret multi-omic datasets (e.g., RNA-seq, ATAC-seq, ChIP/CUT&RUN/CUT&Tag
-
projects focusing on hPSC differentiation, and modeling neurodegenerative diseases. ● Standardize and optimize advanced molecular and imaging assays ● Analyze complex multi-omic or functional datasets
-
processing all billable services for YM. Document, implement and monitor policies and operational workflows to streamline and optimize charge capture, ensuring accuracy and timeliness. Develop and monitor
-
to refine mechanisms understanding and optimize treatment for mental health using computational tools, with a particular focus on developing ecologically valid computational frameworks and models. Our
-
, onboarding, training, performance management, and scheduling; development and optimization of clinic templates; monitoring and improving productivity and documentation completion (including timely closure
-
the most common PET isotopes (11C, 15O, 13N, and 18F); and an imaging and data analysis section that oversees scanning procedures and optimizes data acquisition and analysis. The Yale University PET Center
-
Interpretation • Contribute to design, execution, and ongoing optimization of the hybrid trial evaluating COAST-AL across Mobile County Health Department (MCHD) service areas. • Support measurement and
-
focused on HIV prevention. Key Responsibilities Data Analysis and Interpretation • Contribute to design, execution, and ongoing optimization of the hybrid trial evaluating COAST-AL